Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors

NCT00390156 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor

Interventions

BIOLOGICAL: bevacizumab
DRUG: cyclophosphamide
DRUG: imatinib

Sponsor

University of California, San Francisco

Collaborators

[object Object]